Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 386 articles:
HTML format
Text format



Single Articles


    January 2019
  1. ZEBERTAVAGE L, Bambina S, Shugart J, Alice A, et al
    A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
    PLoS One. 2019;14:e0209153.
    PubMed     Text format     Abstract available


  2. HODGINS B, Pillet S, Landry N, Ward BJ, et al
    A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities.
    PLoS One. 2019;14:e0210009.
    PubMed     Text format     Abstract available


  3. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0210081.
    PubMed     Text format     Abstract available


  4. PERNICIARO S, Imohl M, Fitzner C, van der Linden M, et al
    Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany.
    PLoS One. 2019;14:e0210278.
    PubMed     Text format     Abstract available


  5. LEE YY, Wang Z
    Facilitators and barriers for healthcare providers to recommend HPV vaccination to attendees of public sexually transmitted diseases clinics in Hong Kong, China.
    PLoS One. 2019;14:e0209942.
    PubMed     Text format     Abstract available


  6. ATCHESON E, Bauza K, Reyes-Sandoval A
    A probabilistic model of pre-erythrocytic malaria vaccine combination in mice.
    PLoS One. 2019;14:e0209028.
    PubMed     Text format     Abstract available


  7. NYARI S, Booth R, Quigley BL, Waugh CA, et al
    Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
    PLoS One. 2019;14:e0210245.
    PubMed     Text format     Abstract available


  8. YOU JHS, Ming WK, Tsang OT, Chan PK, et al
    Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.
    PLoS One. 2019;14:e0210005.
    PubMed     Text format     Abstract available


  9. KISLAYA I, Rodrigues AP, Sousa-Uva M, Gomez V, et al
    Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
    PLoS One. 2019;14:e0209428.
    PubMed     Text format     Abstract available


  10. WORMSBECKER AE, Johnson C, Bourns L, Harris T, et al
    Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
    PLoS One. 2019;14:e0210833.
    PubMed     Text format     Abstract available


  11. BAHEMUKA UM, Abaasa A, Ruzagira E, Lindan C, et al
    Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.
    PLoS One. 2019;14:e0198460.
    PubMed     Text format     Abstract available


  12. OGBUANU IU, Li AJ, Anya BM, Tamadji M, et al
    Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology.
    PLoS One. 2019;14:e0210648.
    PubMed     Text format     Abstract available


  13. ROSANOWSKI SM, Carpenter TE, Adamson D, Rogers CW, et al
    An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country.
    PLoS One. 2019;14:e0210885.
    PubMed     Text format     Abstract available


  14. PRIMO ME, Thompson CS, Valentini BS, Sarli M, et al
    Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.
    PLoS One. 2019;14:e0211149.
    PubMed     Text format     Abstract available


  15. HOULE SKD, Eurich DT
    Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada.
    PLoS One. 2019;14:e0211006.
    PubMed     Text format     Abstract available


  16. CUI J, O'Connell CM, Costa A, Pan Y, et al
    A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0208801.
    PubMed     Text format     Abstract available


  17. ROCKSTROH JK, Asmuth D, Pantaleo G, Clotet B, et al
    Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
    PLoS One. 2019;14:e0210965.
    PubMed     Text format     Abstract available


  18. CASAL J, Saegerman C, Bertagnoli S, Meyer G, et al
    A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France.
    PLoS One. 2019;14:e0210317.
    PubMed     Text format     Abstract available


  19. ESPANA G, Hogea C, Guignard A, Ten Bosch QA, et al
    Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.
    PLoS One. 2019;14:e0210041.
    PubMed     Text format     Abstract available


  20. YUN JW, Choi MJ, Shin GS, Lim JO, et al
    Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    PLoS One. 2019;14:e0209643.
    PubMed     Text format     Abstract available


  21. MARTINEZ L, Milanic M, Malaina I, Alvarez C, et al
    Weighted lambda superstrings applied to vaccine design.
    PLoS One. 2019;14:e0211714.
    PubMed     Text format     Abstract available


  22. KIM HW, Lee HY, Kim SE, Ahn HY, et al
    Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea.
    PLoS One. 2019;14:e0211475.
    PubMed     Text format     Abstract available


  23. LEVY C, Varon E, Ouldali N, Wollner A, et al
    Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.
    PLoS One. 2019;14:e0211712.
    PubMed     Text format     Abstract available


  24. CHAKRABARTI A, Grepin KA, Helleringer S
    The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
    PLoS One. 2019;14:e0212049.
    PubMed     Text format     Abstract available


  25. MEDISE BE, Soedjatmiko S, Rengganis I, Gunardi H, et al
    Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
    PLoS One. 2019;14:e0211784.
    PubMed     Text format     Abstract available


  26. WILDE S, Jiang Y, Tafoya AM, Horsman J, et al
    Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.
    PLoS One. 2019;14:e0197721.
    PubMed     Text format     Abstract available


  27. CUI J, O'Connell CM, Costa A, Pan Y, et al
    Correction: A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0213091.
    PubMed     Text format     Abstract available


  28. REUSCHEL E, Jilg W, Seelbach-Goebel B, Deml L, et al
    Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    PLoS One. 2019;14:e0212800.
    PubMed     Text format     Abstract available


  29. GUERRA-MAUPOME M, Vang DX, McGill JL
    Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    PLoS One. 2019;14:e0212751.
    PubMed     Text format     Abstract available


  30. ALCOLEA PJ, Alonso A, Esteban A, Peris P, et al
    IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.
    PLoS One. 2019;14:e0212136.
    PubMed     Text format     Abstract available


  31. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0212957.
    PubMed     Text format     Abstract available


  32. NGOCHO JS, Magoma B, Olomi GA, Mahande MJ, et al
    Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.
    PLoS One. 2019;14:e0212295.
    PubMed     Text format     Abstract available


  33. BOULTON ML, Carlson BF, Wagner AL, Porth JM, et al
    Vaccination timeliness among newborns and infants in Ethiopia.
    PLoS One. 2019;14:e0212408.
    PubMed     Text format     Abstract available


  34. TUMIOTTO C, Alves BM, Recordon-Pinson P, Jourdain M, et al
    Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
    PLoS One. 2019;14:e0212347.
    PubMed     Text format     Abstract available


  35. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    PubMed     Text format     Abstract available


  36. KELLY JD, Worden L, Wannier SR, Hoff NA, et al
    Projections of Ebola outbreak size and duration with and without vaccine use in Equateur, Democratic Republic of Congo, as of May 27, 2018.
    PLoS One. 2019;14:e0213190.
    PubMed     Text format     Abstract available


  37. SRIVASTAV A, O'Halloran A, Lu PJ, Williams WW, et al
    Vaccination differences among U.S. adults by their self-identified sexual orientation, National Health Interview Survey, 2013-2015.
    PLoS One. 2019;14:e0213431.
    PubMed     Text format     Abstract available


  38. KIM HJ, Son HS, Lee SW, Yoon Y, et al
    Efficient expression of enterovirus 71 based on virus-like particles vaccine.
    PLoS One. 2019;14:e0210477.
    PubMed     Text format     Abstract available


  39. VAN DER WEELE P, Breeuwsma M, Donken R, van Logchem E, et al
    Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.
    PLoS One. 2019;14:e0212927.
    PubMed     Text format     Abstract available


  40. DABRAL N, Burcham GN, Jain-Gupta N, Sriranganathan N, et al
    Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    PLoS One. 2019;14:e0213587.
    PubMed     Text format     Abstract available


  41. MOHAMMED H, McMillan M, Roberts CT, Marshall HS, et al
    A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.
    PLoS One. 2019;14:e0214538.
    PubMed     Text format     Abstract available


  42. THILAKARATHNE DS, Coppo MJC, Hartley CA, Diaz-Mendez A, et al
    Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    PLoS One. 2019;14:e0213866.
    PubMed     Text format     Abstract available


  43. MUNUSAMY PONNAN S, Pattabiram S, Thiruvengadam K, Goyal R, et al
    Induction and maintenance of bi-functional (IFN-gamma + IL-2+ and IL-2+ TNF-alpha+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2019;14:e0213911.
    PubMed     Text format     Abstract available


  44. MWANGOME M, Ngari M, Bwahere P, Kabore P, et al
    Anthropometry at birth and at age of routine vaccination to predict mortality in the first year of life: A birth cohort study in BukinaFaso.
    PLoS One. 2019;14:e0213523.
    PubMed     Text format     Abstract available


  45. BERNSTEIN DI, Cardin RD, Pullum DA, Bravo FJ, et al
    Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.
    PLoS One. 2019;14:e0213401.
    PubMed     Text format     Abstract available


  46. WIBABARA Y, Banura C, Kalyango J, Karamagi C, et al
    Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences.
    PLoS One. 2019;14:e0214732.
    PubMed     Text format     Abstract available


  47. MAENETJE P, Lindan C, Makkan H, Chetty-Makkan CM, et al
    HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.
    PLoS One. 2019;14:e0214786.
    PubMed     Text format     Abstract available


  48. VUPPUTURI S, Rubenstein KB, Derus AJ, Loftus BC, et al
    Factors contributing to racial disparities in influenza vaccinations.
    PLoS One. 2019;14:e0213972.
    PubMed     Text format     Abstract available


  49. MESA KA, Yu B, Wrin T, Petropoulos CJ, et al
    Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
    PLoS One. 2019;14:e0213409.
    PubMed     Text format     Abstract available


  50. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey.
    PLoS One. 2019;14:e0215125.
    PubMed     Text format     Abstract available


    January 2018
  51. WU PW, Huang CC, Chao WC, Sun CC, et al
    Impact of influenza vaccine on childhood otitis media in Taiwan: A population-based study.
    PLoS One. 2018;13:e0190507.
    PubMed     Text format     Abstract available


  52. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0189571.
    PubMed     Text format     Abstract available


  53. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    PubMed     Text format     Abstract available


  54. ZUST R, Li SH, Xie X, Velumani S, et al
    Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
    PLoS One. 2018;13:e0189262.
    PubMed     Text format     Abstract available


  55. WALLACE RM, Lai Y, Doty JB, Chen CC, et al
    Initial pen and field assessment of baits to use in oral rabies vaccination of Formosan ferret-badgers in response to the re-emergence of rabies in Taiwan.
    PLoS One. 2018;13:e0189998.
    PubMed     Text format     Abstract available


  56. MBULAWA ZZA, van Schalkwyk C, Hu NC, Meiring TL, et al
    High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.
    PLoS One. 2018;13:e0190166.
    PubMed     Text format     Abstract available


  57. TARIGAN S, Wibowo MH, Indriani R, Sumarningsih S, et al
    Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    PLoS One. 2018;13:e0190947.
    PubMed     Text format     Abstract available


  58. CAROLAN K, Verran J, Crossley M, Redfern J, et al
    Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: A pilot study.
    PLoS One. 2018;13:e0190984.
    PubMed     Text format     Abstract available


  59. NOYCE RS, Lederman S, Evans DH
    Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
    PLoS One. 2018;13:e0188453.
    PubMed     Text format     Abstract available


  60. HAMMAMI P, Lancelot R, Domenech J, Lesnoff M, et al
    Ex-ante assessment of different vaccination-based control schedules against the peste des petits ruminants virus in sub-Saharan Africa.
    PLoS One. 2018;13:e0190296.
    PubMed     Text format     Abstract available


  61. KIM AR, Lee DH, Lee SH, Rubino I, et al
    Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
    PLoS One. 2018;13:e0191277.
    PubMed     Text format     Abstract available


  62. FERNANDEZ-ARIAS C, Arias CF, Zhang M, Herrero MA, et al
    Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.
    PLoS One. 2018;13:e0190940.
    PubMed     Text format     Abstract available


  63. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Correction: Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2018;13:e0191378.
    PubMed     Text format     Abstract available


  64. LEE YT, Ko EJ, Lee Y, Kim KH, et al
    Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
    PLoS One. 2018;13:e0190868.
    PubMed     Text format     Abstract available


  65. BAUMGAERTNER B, Carlisle JE, Justwan F
    The influence of political ideology and trust on willingness to vaccinate.
    PLoS One. 2018;13:e0191728.
    PubMed     Text format     Abstract available


  66. KIM H, Kimoto T, Sakai S, Takahashi E, et al
    Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    PLoS One. 2018;13:e0191133.
    PubMed     Text format     Abstract available


  67. HARALAMBIEVA IH, Kennedy RB, Simon WL, Goergen KM, et al
    Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.
    PLoS One. 2018;13:e0191812.
    PubMed     Text format     Abstract available


  68. OPRIESSNIG T, Gauger PC, Gerber PF, Castro AMMG, et al
    Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.
    PLoS One. 2018;13:e0191739.
    PubMed     Text format     Abstract available


  69. ALLARD D, Charlebois R, Gilbert L, Stagg J, et al
    CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination.
    PLoS One. 2018;13:e0191973.
    PubMed     Text format     Abstract available


  70. TUTYKHINA I, Esmagambetov I, Bagaev A, Pichugin A, et al
    Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
    PLoS One. 2018;13:e0191574.
    PubMed     Text format     Abstract available


  71. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    PubMed     Text format     Abstract available


  72. SASAKI E, Momose H, Hiradate Y, Furuhata K, et al
    Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
    PLoS One. 2018;13:e0191896.
    PubMed     Text format     Abstract available


  73. GRANDAHL M, Chun Paek S, Grisurapong S, Sherer P, et al
    Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0193054.
    PubMed     Text format     Abstract available


  74. VERANI JR, Massora S, Acacio S, Dos Santos RT, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.
    PLoS One. 2018;13:e0191113.
    PubMed     Text format     Abstract available


  75. GIACOMET V, Masetti M, Nannini P, Forlanini F, et al
    Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults.
    PLoS One. 2018;13:e0192638.
    PubMed     Text format     Abstract available


  76. WILSON SE, Chung H, Schwartz KL, Guttmann A, et al
    Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.
    PLoS One. 2018;13:e0192809.
    PubMed     Text format     Abstract available


  77. BASKIN E
    Increasing influenza vaccination rates via low cost messaging interventions.
    PLoS One. 2018;13:e0192594.
    PubMed     Text format     Abstract available


  78. SHAH MP, Dahl RM, Parashar UD, Lopman BA, et al
    Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States.
    PLoS One. 2018;13:e0191429.
    PubMed     Text format     Abstract available


  79. HALL MT, Simms KT, Lew JB, Smith MA, et al
    Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
    PLoS One. 2018;13:e0185332.
    PubMed     Text format     Abstract available


  80. KAWAKAMI R, Nozato Y, Nakagami H, Ikeda Y, et al
    Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.
    PLoS One. 2018;13:e0191895.
    PubMed     Text format     Abstract available


  81. LEE RU, Won SH, Hansen C, Crum-Cianflone NF, et al
    25-hydroxyvitamin D, influenza vaccine response and healthcare encounters among a young adult population.
    PLoS One. 2018;13:e0192479.
    PubMed     Text format     Abstract available


  82. THORRINGTON D, van Rossum L, Knol M, de Melker H, et al
    Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.
    PLoS One. 2018;13:e0192640.
    PubMed     Text format     Abstract available


  83. BERKHOUT C, Willefert-Bouche A, Chazard E, Zgorska-Maynard-Moussa S, et al
    Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms.
    PLoS One. 2018;13:e0192155.
    PubMed     Text format     Abstract available


  84. NEWMAN LP, Bhat N, Fleming JA, Neuzil KM, et al
    Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.
    PLoS One. 2018;13:e0193263.
    PubMed     Text format     Abstract available


  85. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0192312.
    PubMed     Text format     Abstract available


  86. BISSA M, Forlani G, Zanotto C, Tosi G, et al
    Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes.
    PLoS One. 2018;13:e0190869.
    PubMed     Text format     Abstract available


  87. SIGAUQUE B, Kobayashi M, Vubil D, Nhacolo A, et al
    Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.
    PLoS One. 2018;13:e0191193.
    PubMed     Text format     Abstract available


  88. YOSHIKAWA T, Fujii H, Okutani A, Shibamura M, et al
    Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
    PLoS One. 2018;13:e0192725.
    PubMed     Text format     Abstract available



  89. Correction: Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2018;13:e0193631.
    PubMed     Text format     Abstract available


  90. WOOD PL, Steinman M, Erol E, Carter C, et al
    Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses.
    PLoS One. 2018;13:e0193424.
    PubMed     Text format     Abstract available


  91. SCHERER AM, Schacht Reisinger H, Schweizer ML, Askelson NM, et al
    Cross-sectional associations between psychological traits, and HPV vaccine uptake and intentions in young adults from the United States.
    PLoS One. 2018;13:e0193363.
    PubMed     Text format     Abstract available


  92. WHITE M, Freistaedter A, Jones GJB, Zervos E, et al
    Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
    PLoS One. 2018;13:e0193131.
    PubMed     Text format     Abstract available


  93. XU K, Zhao Q, Wen X, Wu R, et al
    A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.
    PLoS One. 2018;13:e0191286.
    PubMed     Text format     Abstract available


  94. MOR Z, Amit Aharon A, Sheffer R, Nehama H, et al
    Growth, developmental achievements and vaccines timeliness of undocumented migrant children from Eritrea compared with Israelis.
    PLoS One. 2018;13:e0193219.
    PubMed     Text format     Abstract available


  95. GONZALEZ-SANCHEZ ME, Cuquerella M, Alunda JM
    Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose.
    PLoS One. 2018;13:e0193118.
    PubMed     Text format     Abstract available


  96. YUEN WWY, Lee A, Chan PKS, Tran L, et al
    Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.
    PLoS One. 2018;13:e0194159.
    PubMed     Text format     Abstract available


  97. FERNANDO N, Natoli R, Racic T, Wooff Y, et al
    The use of the vaccinia virus complement control protein (VCP) in the rat retina.
    PLoS One. 2018;13:e0193740.
    PubMed     Text format     Abstract available


  98. EBRAHIMI-NIK H, Bassami MR, Mohri M, Rad M, et al
    Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
    PLoS One. 2018;13:e0194888.
    PubMed     Text format     Abstract available


  99. CASALINO E, Ghazali A, Bouzid D, Antoniol S, et al
    Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.
    PLoS One. 2018;13:e0193029.
    PubMed     Text format     Abstract available


  100. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    PubMed     Text format     Abstract available


  101. ANDREAE CA, Sessions RB, Virji M, Hill DJ, et al
    Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.
    PLoS One. 2018;13:e0193940.
    PubMed     Text format     Abstract available


  102. VISSERS M, Wijmenga-Monsuur AJ, Knol MJ, Badoux P, et al
    Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.
    PLoS One. 2018;13:e0194823.
    PubMed     Text format     Abstract available


  103. NAPOLITANO F, Navaro M, Vezzosi L, Santagati G, et al
    Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy.
    PLoS One. 2018;13:e0194920.
    PubMed     Text format     Abstract available


  104. HACHIYA M, Miyano S, Mori Y, Vynnycky E, et al
    Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    PLoS One. 2018;13:e0194931.
    PubMed     Text format     Abstract available


  105. SHAHID MA, Marenda MS, Markham PF, Noormohammadi AH, et al
    Complementation of the Mycoplasma synoviae MS-H vaccine strain with wild-type obg influencing its growth characteristics.
    PLoS One. 2018;13:e0194528.
    PubMed     Text format     Abstract available


  106. JANG H, Elaish M, Kc M, Abundo MC, et al
    Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    PLoS One. 2018;13:e0195285.
    PubMed     Text format     Abstract available


  107. GRAY DW, Welsh MD, Mansoor F, Doherty S, et al
    DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles.
    PLoS One. 2018;13:e0194488.
    PubMed     Text format     Abstract available


  108. TRAMUTO F, Maida CM, Pojero F, Colomba GME, et al
    Case-based surveillance of measles in Sicily during 2012-2017: The changing molecular epidemiology and implications for vaccine strategies.
    PLoS One. 2018;13:e0195256.
    PubMed     Text format     Abstract available


  109. RAJENDRAN M, Sun W, Comella P, Nachbagauer R, et al
    An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    PLoS One. 2018;13:e0194830.
    PubMed     Text format     Abstract available


  110. OVERTON ET, Lawrence SJ, Wagner E, Nopora K, et al
    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
    PLoS One. 2018;13:e0195897.
    PubMed     Text format     Abstract available


  111. SHERMAN SM, Nailer E
    Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK.
    PLoS One. 2018;13:e0195801.
    PubMed     Text format     Abstract available


  112. ZHOU JJ, Wang YM, Lee VWS, Zhang GY, et al
    DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    PLoS One. 2018;13:e0195657.
    PubMed     Text format     Abstract available


  113. WANG J, Hilchey SP, DeDiego M, Perry S, et al
    Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
    PLoS One. 2018;13:e0193680.
    PubMed     Text format     Abstract available


  114. GUARDO AC, Gomez CE, Diaz-Brito V, Pich J, et al
    Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2018;13:e0195915.
    PubMed     Text format     Abstract available


  115. GRANDAHL M, Paek SC, Grisurapong S, Sherer P, et al
    Correction: Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0196437.
    PubMed     Text format     Abstract available


  116. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0196367.
    PubMed     Text format     Abstract available


  117. VAN RAVENHORST MB, den Hartog G, van der Klis FRM, van Rooijen DM, et al
    Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
    PLoS One. 2018;13:e0191261.
    PubMed     Text format     Abstract available


  118. MARLET J, Gaudy-Graffin C, Marc D, Boennec R, et al
    Factors associated with influenza vaccination failure and severe disease in a French region in 2015.
    PLoS One. 2018;13:e0195611.
    PubMed     Text format     Abstract available


  119. AKAPIRAT S, Karnasuta C, Vasan S, Rerks-Ngarm S, et al
    Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
    PLoS One. 2018;13:e0196397.
    PubMed     Text format     Abstract available


  120. TOVAR C, Patchett AL, Kim V, Wilson R, et al
    Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    PLoS One. 2018;13:e0196469.
    PubMed     Text format     Abstract available


  121. VOYSEY M, Pollard AJ, Perera R, Shrestha S, et al
    Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
    PLoS One. 2018;13:e0196200.
    PubMed     Text format     Abstract available


  122. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0196546.
    PubMed     Text format     Abstract available


  123. DORAN RC, Tatsuno GP, O'Rourke SM, Yu B, et al
    Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
    PLoS One. 2018;13:e0196370.
    PubMed     Text format     Abstract available


  124. MCCORMICK AA, Shakeel A, Yi C, Kaur H, et al
    Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    PLoS One. 2018;13:e0194614.
    PubMed     Text format     Abstract available


  125. GIL DE LOS SANTOS D, Gil de Los Santos JR, Gil-Turnes C, Gaboardi G, et al
    Probiotic effect of Pichia pastoris X-33 produced in parboiled rice effluent and YPD medium on broiler chickens.
    PLoS One. 2018;13:e0192904.
    PubMed     Text format     Abstract available


  126. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    PubMed     Text format     Abstract available


  127. KHAN A, Junaid M, Kaushik AC, Ali A, et al
    Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.
    PLoS One. 2018;13:e0196484.
    PubMed     Text format     Abstract available


  128. NUISMER SL, May R, Basinski A, Remien CH, et al
    Controlling epidemics with transmissible vaccines.
    PLoS One. 2018;13:e0196978.
    PubMed     Text format     Abstract available


  129. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Text format     Abstract available


  130. BUMGARDNER SA, Zhang L, LaVoy AS, Andre B, et al
    Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
    PLoS One. 2018;13:e0196950.
    PubMed     Text format     Abstract available


  131. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0196564.
    PubMed     Text format     Abstract available


  132. BORTHWICK NJ, Lane T, Moyo N, Crook A, et al
    Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    PLoS One. 2018;13:e0197299.
    PubMed     Text format     Abstract available


  133. PAULY M, Black AP, Khampanisong P, Nouanthong P, et al
    Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    PLoS One. 2018;13:e0197370.
    PubMed     Text format     Abstract available


  134. MARLEY KB, Kuehn LA, Keele JW, Wileman BW, et al
    Genetic variation in humoral response to an Escherichia coli O157:H7 vaccine in beef cattle.
    PLoS One. 2018;13:e0197347.
    PubMed     Text format     Abstract available


  135. MUELLER SW, Baumgartner LJ, MacLaren R, Neumann R, et al
    Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.
    PLoS One. 2018;13:e0197037.
    PubMed     Text format     Abstract available


  136. MANOHARAN VK, Varghese BP, Paldurai A, Samal SK, et al
    Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    PLoS One. 2018;13:e0197253.
    PubMed     Text format     Abstract available


  137. NEIRA V, Allerson M, Corzo C, Culhane M, et al
    Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.
    PLoS One. 2018;13:e0197600.
    PubMed     Text format     Abstract available


  138. HUANG Z, Sun X, Wagner AL, Ren J, et al
    Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China.
    PLoS One. 2018;13:e0197437.
    PubMed     Text format     Abstract available



  139. Correction: Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0198577.
    PubMed     Text format     Abstract available


  140. SELLENS E, Norris JM, Dhand NK, Heller J, et al
    Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.
    PLoS One. 2018;13:e0198421.
    PubMed     Text format     Abstract available


  141. ILYINSKII PO, Kovalev GI, O'Neil CP, Roy CJ, et al
    Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
    PLoS One. 2018;13:e0197694.
    PubMed     Text format     Abstract available


  142. SHENG X, Liu M, Liu H, Tang X, et al
    Identification of immunogenic proteins and evaluation of recombinant PDHA1 and GAPDH as potential vaccine candidates against Streptococcus iniae infection in flounder (Paralichthys olivaceus).
    PLoS One. 2018;13:e0195450.
    PubMed     Text format     Abstract available


  143. LIU M, Huang M, Shui Y, Biville F, et al
    Roles of B739_1343 in iron acquisition and pathogenesis in Riemerella anatipestifer CH-1 and evaluation of the RA-CH-1DeltaB739_1343 mutant as an attenuated vaccine.
    PLoS One. 2018;13:e0197310.
    PubMed     Text format     Abstract available


  144. CAYROU C, Akinduko AA, Mirkes EM, Lucidarme J, et al
    Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
    PLoS One. 2018;13:e0197186.
    PubMed     Text format     Abstract available


  145. KOOIJMAN S, Brummelman J, van Els CACM, Marino F, et al
    Vaccine antigens modulate the innate response of monocytes to Al(OH)3.
    PLoS One. 2018;13:e0197885.
    PubMed     Text format     Abstract available


  146. DE PASCALIS R, Hahn A, Brook HM, Ryden P, et al
    A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    PLoS One. 2018;13:e0198140.
    PubMed     Text format     Abstract available


  147. SOUTHERN J, Andrews N, Sandu P, Sheppard CL, et al
    Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
    PLoS One. 2018;13:e0195799.
    PubMed     Text format     Abstract available


  148. KUCHENBECKER U, Chase D, Reichert A, Schiffner-Rohe J, et al
    Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
    PLoS One. 2018;13:e0197905.
    PubMed     Text format     Abstract available


  149. IMAI C, Toizumi M, Hall L, Lambert S, et al
    A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    PLoS One. 2018;13:e0198685.
    PubMed     Text format     Abstract available


  150. SHAHRUDIN S, Chen C, David SC, Singleton EV, et al
    Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
    PLoS One. 2018;13:e0198182.
    PubMed     Text format     Abstract available


  151. POTTINGER HL, Jacobs ET, Haenchen SD, Ernst KC, et al
    Parental attitudes and perceptions associated with childhood vaccine exemptions in high-exemption schools.
    PLoS One. 2018;13:e0198655.
    PubMed     Text format     Abstract available


  152. MOHAMMED H, Clarke M, Koehler A, Watson M, et al
    Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
    PLoS One. 2018;13:e0197867.
    PubMed     Text format     Abstract available


  153. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    PubMed     Text format     Abstract available


  154. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    The views of the general public on prioritising vaccination programmes against childhood diseases: A qualitative study.
    PLoS One. 2018;13:e0197374.
    PubMed     Text format     Abstract available


  155. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Text format     Abstract available


  156. GROPPO R, DiNapoli J, Il Jeong K, Kishko M, et al
    Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
    PLoS One. 2018;13:e0199452.
    PubMed     Text format     Abstract available


  157. SU JR, Ng C, Lewis PW, Cano MV, et al
    Adverse events after vaccination among HIV-positive persons, 1990-2016.
    PLoS One. 2018;13:e0199229.
    PubMed     Text format     Abstract available


  158. CHIT A, Zivaripiran H, Shin T, Lee JKH, et al
    Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.
    PLoS One. 2018;13:e0197970.
    PubMed     Text format     Abstract available


  159. CHEUNG T, Lau JTF, Wang JZ, Mo PKH, et al
    Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong.
    PLoS One. 2018;13:e0198615.
    PubMed     Text format     Abstract available


  160. HORSINGTON J, Nfon C, Bittner H, Durr PA, et al
    The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.
    PLoS One. 2018;13:e0195302.
    PubMed     Text format     Abstract available


  161. DE SMEDT T, Merrall E, Macina D, Perez-Vilar S, et al
    Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    PLoS One. 2018;13:e0199180.
    PubMed     Text format     Abstract available


  162. NYARI S, Khan SA, Rawlinson G, Waugh CA, et al
    Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    PLoS One. 2018;13:e0200112.
    PubMed     Text format     Abstract available


  163. WU AG, Shah AS, Haelle TS, Lunos SA, et al
    Choosing the perfect shot - The loaded narrative of imagery in online news coverage of vaccines.
    PLoS One. 2018;13:e0199870.
    PubMed     Text format     Abstract available


  164. ZARNITSYNA VI, Bulusheva I, Handel A, Longini IM, et al
    Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.
    PLoS One. 2018;13:e0199674.
    PubMed     Text format     Abstract available


  165. IMAI N, Ferguson NM
    Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design.
    PLoS One. 2018;13:e0199450.
    PubMed     Text format     Abstract available


  166. KARAMPATSAS K, Osborne L, Seah ML, Tong CYW, et al
    Clinical characteristics and complications of rotavirus gastroenteritis in children in east London: A retrospective case-control study.
    PLoS One. 2018;13:e0194009.
    PubMed     Text format     Abstract available


  167. PALING FP, Olsen K, Ohneberg K, Wolkewitz M, et al
    Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.
    PLoS One. 2018;13:e0193445.
    PubMed     Text format     Abstract available


  168. ANDERSON KB, Simasathien S, Watanaveeradej V, Weg AL, et al
    Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    PLoS One. 2018;13:e0193050.
    PubMed     Text format     Abstract available


  169. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0199249.
    PubMed     Text format     Abstract available


  170. SUBAIYA S, Tabu C, N'ganga J, Awes AA, et al
    Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    PLoS One. 2018;13:e0199786.
    PubMed     Text format     Abstract available


  171. SEKULOSKI S, Batzloff MR, Griffin P, Parsonage W, et al
    Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.
    PLoS One. 2018;13:e0198658.
    PubMed     Text format     Abstract available


  172. PORTER CK, Lynen A, Riddle MS, Talaat K, et al
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
    PLoS One. 2018;13:e0194325.
    PubMed     Text format     Abstract available


  173. LEE KS, Lee YR, Park SY, Oh IH, et al
    The economic burden of rotavirus infection in South Korea from 2009 to 2012.
    PLoS One. 2018;13:e0194120.
    PubMed     Text format     Abstract available


  174. JUNG M
    The effect of maternal decisional authority on children's vaccination in East Asia.
    PLoS One. 2018;13:e0200333.
    PubMed     Text format     Abstract available


  175. MARBAIX S, Peetermans WE, Verhaegen J, Annemans L, et al
    Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.
    PLoS One. 2018;13:e0199427.
    PubMed     Text format     Abstract available


  176. ABDUL-CADER MS, Amarasinghe A, Palomino-Tapia V, Ahmed-Hassan H, et al
    In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.
    PLoS One. 2018;13:e0193964.
    PubMed     Text format     Abstract available


  177. GENTILE A, Bakir J, Firpo V, Casanueva EV, et al
    PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina.
    PLoS One. 2018;13:e0199989.
    PubMed     Text format     Abstract available


  178. MERIKI HD, Tufon KA, Anong DN, Tony NJ, et al
    Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon.
    PLoS One. 2018;13:e0200157.
    PubMed     Text format     Abstract available


  179. WEN Y, Trinh HV, Linton CE, Tani C, et al
    Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    PLoS One. 2018;13:e0194266.
    PubMed     Text format     Abstract available


  180. GIBSON AD, Mazeri S, Lohr F, Mayer D, et al
    One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns.
    PLoS One. 2018;13:e0200942.
    PubMed     Text format     Abstract available


  181. SHEN K, Wasserman M, Liu D, Yang YH, et al
    Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China.
    PLoS One. 2018;13:e0201245.
    PubMed     Text format     Abstract available


  182. OMINDE M, Sande J, Ooko M, Bottomley C, et al
    Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya.
    PLoS One. 2018;13:e0200715.
    PubMed     Text format     Abstract available


  183. LEE HS, Thiem VD, Anh DD, Duong TN, et al
    Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015.
    PLoS One. 2018;13:e0194943.
    PubMed     Text format     Abstract available


  184. LIANG H, Yang R, Liu Z, Li M, et al
    Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    PLoS One. 2018;13:e0194860.
    PubMed     Text format     Abstract available


  185. KAUFMAN J, Ryan R, Hill S
    Qualitative focus groups with stakeholders identify new potential outcomes related to vaccination communication.
    PLoS One. 2018;13:e0201145.
    PubMed     Text format     Abstract available


  186. BAKER DL, Powers JG, Ransom JI, McCann BE, et al
    Reimmunization increases contraceptive effectiveness of gonadotropin-releasing hormone vaccine (GonaCon-Equine) in free-ranging horses (Equus caballus): Limitations and side effects.
    PLoS One. 2018;13:e0201570.
    PubMed     Text format     Abstract available


  187. LEE MF, Chiang CH, Li YL, Wang NM, et al
    Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model.
    PLoS One. 2018;13:e0201281.
    PubMed     Text format     Abstract available


  188. MAZAGATOS C, Delgado-Sanz C, Oliva J, Gherasim A, et al
    Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    PLoS One. 2018;13:e0200934.
    PubMed     Text format     Abstract available


  189. MUNGUAMBE AM, de Almeida AECC, Nhantumbo AA, Come CE, et al
    Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    PLoS One. 2018;13:e0197390.
    PubMed     Text format     Abstract available


  190. PURRINOS-HERMIDA MJ, Santiago-Perez MI, Trevino M, Dopazo R, et al
    Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain.
    PLoS One. 2018;13:e0201653.
    PubMed     Text format     Abstract available


  191. BROWN DW, Tabu C, Sergon K, Shendale S, et al
    Home-based record (HBR) ownership and use of HBR recording fields in selected Kenyan communities: Results from the Kenya Missed Opportunities for Vaccination Assessment.
    PLoS One. 2018;13:e0201538.
    PubMed     Text format     Abstract available


  192. O'ROURKE SM, Byrne G, Tatsuno G, Wright M, et al
    Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
    PLoS One. 2018;13:e0197656.
    PubMed     Text format     Abstract available


  193. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    PubMed     Text format     Abstract available


  194. POSUWAN N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, et al
    Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    PLoS One. 2018;13:e0202637.
    PubMed     Text format     Abstract available


  195. RANFAING J, Dunyach-Remy C, Lavigne JP, Sotto A, et al
    Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli.
    PLoS One. 2018;13:e0202609.
    PubMed     Text format     Abstract available


  196. KLYZ A, Piekarowicz A
    Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates.
    PLoS One. 2018;13:e0202437.
    PubMed     Text format     Abstract available


  197. TSYBALOVA LM, Stepanova LA, Shuklina MA, Mardanova ES, et al
    Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    PLoS One. 2018;13:e0201429.
    PubMed     Text format     Abstract available


  198. MARITAN M, Veggi D, Cozzi R, Dello Iacono L, et al
    Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody.
    PLoS One. 2018;13:e0201922.
    PubMed     Text format     Abstract available


  199. AL MAHTAB M, Akbar SMF, Aguilar JC, Guillen G, et al
    Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).
    PLoS One. 2018;13:e0201236.
    PubMed     Text format     Abstract available



  200. Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2018;13:e0203635.
    PubMed     Text format    


  201. MUNUSAMY PONNAN S, Swaminathan S, Tiruvengadam K, K K V, et al
    Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0203037.
    PubMed     Text format     Abstract available


  202. LI H, Hai Y, Lim SY, Toledo N, et al
    Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
    PLoS One. 2018;13:e0202997.
    PubMed     Text format     Abstract available


  203. SANAPALA S, Mosca L, Wang S, Curtiss R, et al
    Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence.
    PLoS One. 2018;13:e0203526.
    PubMed     Text format     Abstract available


  204. VOYSEY M, Sadarangani M, Pollard AJ, Fanshawe TR, et al
    Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias.
    PLoS One. 2018;13:e0202517.
    PubMed     Text format     Abstract available


  205. BOZIO CH, Abdul-Karim A, Abenyeri J, Abubakari B, et al
    Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2018;13:e0203205.
    PubMed     Text format     Abstract available


  206. HEGERLE N, Choi M, Sinclair J, Amin MN, et al
    Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    PLoS One. 2018;13:e0203143.
    PubMed     Text format     Abstract available


  207. MATTHIJSSE SM, Naber SK, Hontelez JAC, Bakker R, et al
    The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
    PLoS One. 2018;13:e0202924.
    PubMed     Text format     Abstract available


  208. LI J, Helal ZH, Karch CP, Mishra N, et al
    A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.
    PLoS One. 2018;13:e0203771.
    PubMed     Text format     Abstract available


  209. HOWLADER DR, Koley H, Sinha R, Maiti S, et al
    Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
    PLoS One. 2018;13:e0203631.
    PubMed     Text format     Abstract available


  210. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Text format     Abstract available


  211. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2018;13:e0204759.
    PubMed     Text format     Abstract available


  212. ELIZAGA ML, Li SS, Kochar NK, Wilson GJ, et al
    Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
    PLoS One. 2018;13:e0202753.
    PubMed     Text format     Abstract available



  213. Correction: Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0204476.
    PubMed     Text format     Abstract available


  214. BALOGUN F, Omotade O
    "She must have been sleeping around"...: Contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria.
    PLoS One. 2018;13:e0203950.
    PubMed     Text format     Abstract available


  215. ALLEN JD, Ray S, Ross TM
    Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0204284.
    PubMed     Text format     Abstract available


  216. ROSTAMIAN M, Bahrami F, Niknam HM
    Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    PLoS One. 2018;13:e0204491.
    PubMed     Text format     Abstract available


  217. SEMA BALTAZAR C, Rafael F, Langa JPM, Chicumbe S, et al
    Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    PLoS One. 2018;13:e0198592.
    PubMed     Text format     Abstract available


  218. SOBHKHEZ M, Krasnov A, Robertsen B
    Transcriptome analyses of Atlantic salmon muscle genes induced by a DNA vaccine against salmonid alphavirus, the causative agent of salmon pancreas disease (PD).
    PLoS One. 2018;13:e0204924.
    PubMed     Text format     Abstract available


  219. BAETEN LA, Podell BK, Sluder AE, Garritsen A, et al
    Standardized guinea pig model for Q fever vaccine reactogenicity.
    PLoS One. 2018;13:e0205882.
    PubMed     Text format     Abstract available


  220. LAU JTF, Ng CSM, Wu AMS, Ma YL, et al
    Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors.
    PLoS One. 2018;13:e0205561.
    PubMed     Text format     Abstract available


  221. DA SILVA EN, Baker A, Alshekaili J, Karpe K, et al
    A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.
    PLoS One. 2018;13:e0204477.
    PubMed     Text format     Abstract available


  222. TONUI T, Corredor-Moreno P, Kanduma E, Njuguna J, et al
    Transcriptomics reveal potential vaccine antigens and a drastic increase of upregulated genes during Theileria parva development from arthropod to bovine infective stages.
    PLoS One. 2018;13:e0204047.
    PubMed     Text format     Abstract available


  223. ISHIMURA ME, Teixeira D, Silveira GDP, Gambero M, et al
    Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.
    PLoS One. 2018;13:e0205148.
    PubMed     Text format     Abstract available


  224. WHELAN AO, Flick-Smith HC, Homan J, Shen ZT, et al
    Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
    PLoS One. 2018;13:e0200213.
    PubMed     Text format     Abstract available


  225. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0205567.
    PubMed     Text format     Abstract available


  226. PARK S, Lee Y, Kwon YM, Lee YT, et al
    Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
    PLoS One. 2018;13:e0205071.
    PubMed     Text format     Abstract available


  227. LI Z, Swann JL, Keskinocak P
    Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    PLoS One. 2018;13:e0206293.
    PubMed     Text format     Abstract available


  228. JACKSON ML, Diallo AO, Medah I, Bicaba BW, et al
    Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.
    PLoS One. 2018;13:e0206117.
    PubMed     Text format     Abstract available


  229. CHIDUMAYO NN
    System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa.
    PLoS One. 2018;13:e0205884.
    PubMed     Text format     Abstract available


  230. CAMPBELL ZA, Marsh TL, Mpolya EA, Thumbi SM, et al
    Newcastle disease vaccine adoption by smallholder households in Tanzania: Identifying determinants and barriers.
    PLoS One. 2018;13:e0206058.
    PubMed     Text format     Abstract available


  231. O'MALLEY KJ, Bowling JL, Stinson E, Cole KS, et al
    Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0205928.
    PubMed     Text format     Abstract available


  232. HORACIO AN, Silva-Costa C, Lopes E, Ramirez M, et al
    Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
    PLoS One. 2018;13:e0206912.
    PubMed     Text format     Abstract available


  233. HOUSER KV, Yamshchikov GV, Bellamy AR, May J, et al
    DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
    PLoS One. 2018;13:e0206837.
    PubMed     Text format     Abstract available


  234. NYASANI DK, Mutua GN, Sajabi RM, Ng'ang'a JW, et al
    Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    PLoS One. 2018;13:e0206656.
    PubMed     Text format     Abstract available


  235. LI X, Doroshenko A, Osgood ND
    Applying particle filtering in both aggregated and age-structured population compartmental models of pre-vaccination measles.
    PLoS One. 2018;13:e0206529.
    PubMed     Text format     Abstract available


  236. CARTER SP, Robertson A, Palphramand KL, Chambers MA, et al
    Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis.
    PLoS One. 2018;13:e0206136.
    PubMed     Text format     Abstract available


  237. ZHAO H, Xu K, Jiang Z, Shao M, et al
    A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.
    PLoS One. 2018;13:e0207431.
    PubMed     Text format     Abstract available



  238. Correction: Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0207721.
    PubMed     Text format     Abstract available


  239. BECK KB, Honge BL, Olesen JS, Petersen MS, et al
    Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women.
    PLoS One. 2018;13:e0207259.
    PubMed     Text format     Abstract available


  240. JAIN A, Walker JL, Mathur R, Forbes HJ, et al
    Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink.
    PLoS One. 2018;13:e0207183.
    PubMed     Text format     Abstract available


  241. STEPHENSON KE, Keefer MC, Bunce CA, Frances D, et al
    First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
    PLoS One. 2018;13:e0205139.
    PubMed     Text format     Abstract available


  242. WONDIMENEH Y, Tiruneh M, Ferede G, Denekew K, et al
    Hospital based surveillance of congenital rubella syndrome cases in the pre-vaccine era in Amhara Regional State, Ethiopia: A base line information for the country.
    PLoS One. 2018;13:e0207095.
    PubMed     Text format     Abstract available


  243. ABU SEIR R, Azmi K, Hamdan A, Namouz H, et al
    Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
    PLoS One. 2018;13:e0206927.
    PubMed     Text format     Abstract available


  244. MENDES LOBAO W, Duarte FG, Burns JD, de Souza Teles Santos CA, et al
    Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?
    PLoS One. 2018;13:e0206726.
    PubMed     Text format     Abstract available


  245. MARX M, Zumpe M, Troschke-Meurer S, Shah D, et al
    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    PLoS One. 2018;13:e0207320.
    PubMed     Text format     Abstract available


  246. VIEGAS EO, Kroidl A, Munseri PJ, Missanga M, et al
    Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
    PLoS One. 2018;13:e0206838.
    PubMed     Text format     Abstract available


  247. CASSIOLATO AP, Almeida SCG, Andrade AL, Minamisava R, et al
    Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.
    PLoS One. 2018;13:e0208211.
    PubMed     Text format     Abstract available


  248. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    PubMed     Text format     Abstract available


  249. KHAN J, Shil A, Prakash R
    Exploring the spatial heterogeneity in different doses of vaccination coverage in India.
    PLoS One. 2018;13:e0207209.
    PubMed     Text format     Abstract available


  250. SONG IG, Lee H, Yi J, Kim MS, et al
    Health literacy and use of preventive health services among North Korean defectors in the Republic of Korea.
    PLoS One. 2018;13:e0195964.
    PubMed     Text format     Abstract available


  251. BARBOSA COSTA G, Gilbert A, Monroe B, Blanton J, et al
    The influence of poverty and rabies knowledge on healthcare seeking behaviors and dog ownership, Cameroon.
    PLoS One. 2018;13:e0197330.
    PubMed     Text format     Abstract available


  252. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    The relationship between perceptions and self-paid hepatitis B vaccination: A structural equation modeling approach.
    PLoS One. 2018;13:e0208402.
    PubMed     Text format     Abstract available


  253. KORSA MG, Devlin JM, Hartley CA, Browning GF, et al
    Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    PLoS One. 2018;13:e0207611.
    PubMed     Text format     Abstract available


  254. SONG JY, Noh JY, Lee JS, Wie SH, et al
    Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    PLoS One. 2018;13:e0207918.
    PubMed     Text format     Abstract available


  255. RUDENKO L, Kiseleva I, Krutikova E, Stepanova E, et al
    Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    PLoS One. 2018;13:e0208028.
    PubMed     Text format     Abstract available


  256. FLAMAR AL, Bonnabau H, Zurawski S, Lacabaratz C, et al
    HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
    PLoS One. 2018;13:e0207794.
    PubMed     Text format     Abstract available


  257. REN J, Wagner AL, Zheng A, Sun X, et al
    The demographics of vaccine hesitancy in Shanghai, China.
    PLoS One. 2018;13:e0209117.
    PubMed     Text format     Abstract available


  258. PASIN C, Halloran ME, Gilbert PB, Langevin E, et al
    Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
    PLoS One. 2018;13:e0207878.
    PubMed     Text format     Abstract available


  259. TIONO AB, Nebie I, Anagnostou N, Coulibaly AS, et al
    First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
    PLoS One. 2018;13:e0208328.
    PubMed     Text format     Abstract available


  260. SUNAGAR R, Kumar S, Namjoshi P, Rosa SJ, et al
    Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.
    PLoS One. 2018;13:e0207587.
    PubMed     Text format     Abstract available


  261. BETSCH C, Schmid P, Heinemeier D, Korn L, et al
    Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination.
    PLoS One. 2018;13:e0208601.
    PubMed     Text format     Abstract available


  262. ZHANG F, Zhao Q, Quan K, Zhu Z, et al
    Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    PLoS One. 2018;13:e0198207.
    PubMed     Text format     Abstract available


  263. KWAN NCL, Yamada A, Sugiura K
    Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan.
    PLoS One. 2018;13:e0206717.
    PubMed     Text format     Abstract available


  264. HAIWICK G, Hermann J, Roof M, Fergen B, et al
    Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study.
    PLoS One. 2018;13:e0209784.
    PubMed     Text format     Abstract available


  265. KESANOPOULOS K, Bratcher HB, Hong E, Xirogianni A, et al
    Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation.
    PLoS One. 2018;13:e0209919.
    PubMed     Text format     Abstract available


  266. ALLEN JD, Ray S, Ross TM
    Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0210043.
    PubMed     Text format     Abstract available


  267. AMPARO ACB, Jayme SI, Roces MCR, Quizon MCL, et al
    The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
    PLoS One. 2018;13:e0199186.
    PubMed     Text format     Abstract available


  268. DE NARDO P, Gentilotti E, Vairo F, Nguhuni B, et al
    A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination.
    PLoS One. 2018;13:e0197996.
    PubMed     Text format     Abstract available


  269. NUNES MC, Weinberg A, Cutland CL, Jones S, et al
    Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
    PLoS One. 2018;13:e0210124.
    PubMed     Text format     Abstract available


  270. DIMALA CA, Kika BT, Kadia BM, Blencowe H, et al
    Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
    PLoS One. 2018;13:e0209744.
    PubMed     Text format     Abstract available


  271. MAKUMBI F, Byabagambi J, Muwanika R, Kigozi G, et al
    Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda.
    PLoS One. 2018;13:e0209167.
    PubMed     Text format     Abstract available


  272. PAES W, Dowle A, Coldwell J, Leech A, et al
    The Chlamydia trachomatis PmpD adhesin forms higher order structures through disulphide-mediated covalent interactions.
    PLoS One. 2018;13:e0198662.
    PubMed     Text format     Abstract available


  273. THAKUR A, Andrea A, Mikkelsen H, Woodworth JS, et al
    Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.
    PLoS One. 2018;13:e0201253.
    PubMed     Text format     Abstract available


  274. HOSSAIN MU, Omar TM, Alam I, Das KC, et al
    Pathway based therapeutic targets identification and development of an interactive database CampyNIBase of Campylobacter jejuni RM1221 through non-redundant protein dataset.
    PLoS One. 2018;13:e0198170.
    PubMed     Text format     Abstract available


  275. JIANG H, Huai Y, Chen H, Uyeki TM, et al
    Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012.
    PLoS One. 2018;13:e0201312.
    PubMed     Text format     Abstract available


  276. NIX EB, Choi J, Anthes C, Gaultier GN, et al
    Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    PLoS One. 2018;13:e0201282.
    PubMed     Text format     Abstract available


  277. ACHARYA P, Kismul H, Mapatano MA, Hatloy A, et al
    Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
    PLoS One. 2018;13:e0202742.
    PubMed     Text format     Abstract available


  278. STADLER J, Naderer L, Beffort L, Ritzmann M, et al
    Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.
    PLoS One. 2018;13:e0203560.
    PubMed     Text format     Abstract available


  279. PILKERTON CS, Hobbs GR, Lilly C, Knox SS, et al
    Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy.
    PLoS One. 2018;13:e0203330.
    PubMed     Text format     Abstract available


  280. SARAIVA MMS, Moreira Filho ALB, Freitas Neto OC, Silva NMV, et al
    Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut.
    PLoS One. 2018;13:e0203158.
    PubMed     Text format     Abstract available


  281. IN HJ, Lim H, Lee JA, Lee SR, et al
    Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    PLoS One. 2018;13:e0202552.
    PubMed     Text format     Abstract available


  282. DODD CN, de Ridder M, Huang WT, Weibel D, et al
    Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    PLoS One. 2018;13:e0204799.
    PubMed     Text format     Abstract available


  283. CHONG KC, Hu P, Lau S, Jia KM, et al
    Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China.
    PLoS One. 2018;13:e0205339.
    PubMed     Text format     Abstract available


  284. CHUNG CJ, Cha SH, Grimm AL, Ajithdoss D, et al
    Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.
    PLoS One. 2018;13:e0203482.
    PubMed     Text format     Abstract available


  285. ADAMO G, Sturabotti G, Baccolini V, de Soccio P, et al
    Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    PLoS One. 2018;13:e0205147.
    PubMed     Text format     Abstract available


  286. ERDEM G, Singh AK, Brusnahan AJ, Moore AN, et al
    Pneumococcal colonization among tracheostomy tube dependent children.
    PLoS One. 2018;13:e0206305.
    PubMed     Text format     Abstract available


  287. MATHEW E, Zhu H, Connelly SM, Sullivan MA, et al
    Display of the HIV envelope protein at the yeast cell surface for immunogen development.
    PLoS One. 2018;13:e0205756.
    PubMed     Text format     Abstract available


  288. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    PubMed     Text format     Abstract available


    January 2017
  289. JIA B, McNeil LK, Dupont CD, Tsioris K, et al
    Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
    PLoS One. 2017;12:e0183738.
    PubMed     Text format     Abstract available


  290. KANEKO M, Takanashi S, Thongprachum A, Hanaoka N, et al
    Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.
    PLoS One. 2017;12:e0184067.
    PubMed     Text format     Abstract available


  291. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    PubMed     Text format     Abstract available


  292. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Text format     Abstract available


  293. FRAIBERK M, Hajkova M, Krulova M, Kojzarova M, et al
    Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
    PLoS One. 2017;12:e0184870.
    PubMed     Text format     Abstract available


  294. LUEDERS I, Young D, Maree L, van der Horst G, et al
    Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality.
    PLoS One. 2017;12:e0178270.
    PubMed     Text format     Abstract available


  295. EVANGELISTA KV, Lourdault K, Matsunaga J, Haake DA, et al
    Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    PLoS One. 2017;12:e0180004.
    PubMed     Text format     Abstract available


  296. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Text format     Abstract available


  297. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Text format     Abstract available


  298. SARTORI AL, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.
    PLoS One. 2017;12:e0179222.
    PubMed     Text format     Abstract available


  299. PIPKINS HR, Bradshaw JL, Keller LE, Swiatlo E, et al
    Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    PLoS One. 2017;12:e0179159.
    PubMed     Text format     Abstract available


  300. BYBERG S, Ostergaard MD, Rodrigues A, Martins C, et al
    Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
    PLoS One. 2017;12:e0177984.
    PubMed     Text format     Abstract available


  301. WANG G, Yin R, Zhou P, Ding Z, et al
    Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    PLoS One. 2017;12:e0176854.
    PubMed     Text format     Abstract available


  302. VINOD N, Noh HB, Oh S, Ji S, et al
    A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.
    PLoS One. 2017;12:e0185488.
    PubMed     Text format     Abstract available


  303. FABURAY B, McGill J, Jongejan F
    A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.
    PLoS One. 2017;12:e0185495.
    PubMed     Text format     Abstract available


  304. GRIMALDI G JR, Teva A, Dos-Santos CB, Santos FN, et al
    Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    PLoS One. 2017;12:e0185438.
    PubMed     Text format     Abstract available


  305. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    PubMed     Text format     Abstract available


  306. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Text format     Abstract available


  307. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    PubMed     Text format     Abstract available


  308. HSU AP, Tseng CH, Barrat J, Lee SH, et al
    Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers.
    PLoS One. 2017;12:e0184831.
    PubMed     Text format     Abstract available


  309. CAPUCCI S, Wee EG, Schiffner T, LaBranche CC, et al
    HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
    PLoS One. 2017;12:e0181886.
    PubMed     Text format     Abstract available


  310. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    PubMed     Text format     Abstract available


  311. PEREZ LG, Martinez DR, deCamp AC, Pinter A, et al
    V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
    PLoS One. 2017;12:e0180720.
    PubMed     Text format     Abstract available


  312. MINAYA MA, Korom M, Wang H, Belshe RB, et al
    The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.
    PLoS One. 2017;12:e0176687.
    PubMed     Text format     Abstract available


  313. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    PubMed     Text format     Abstract available


  314. FERREYRA-REYES L, Cruz-Hervert LP, Troy SB, Huang C, et al
    Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.
    PLoS One. 2017;12:e0185594.
    PubMed     Text format     Abstract available


  315. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    PubMed     Text format     Abstract available


  316. WARD PR, Attwell K, Meyer SB, Rokkas P, et al
    Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: A qualitative study in Australia.
    PLoS One. 2017;12:e0185955.
    PubMed     Text format     Abstract available


  317. BILLARD MN, De Serres G, Gariepy MC, Boulianne N, et al
    Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
    PLoS One. 2017;12:e0186070.
    PubMed     Text format     Abstract available


  318. MCCURLEY NP, Domi A, Basu R, Saunders KO, et al
    HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
    PLoS One. 2017;12:e0177863.
    PubMed     Text format     Abstract available


  319. SMITH SG, Harris SA, Satti I, Bryan D, et al
    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.
    PLoS One. 2017;12:e0184391.
    PubMed     Text format     Abstract available


  320. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    PubMed     Text format     Abstract available


  321. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    PubMed     Text format     Abstract available


  322. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Text format     Abstract available


  323. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    PubMed     Text format     Abstract available


  324. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Text format     Abstract available


  325. HIGGINS JL, Gonzalez-Juarrero M, Bowen RA
    Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    PLoS One. 2017;12:e0185823.
    PubMed     Text format     Abstract available


  326. VAN DEN BIGGELAAR AHJ, Richmond PC, Fuery A, Anderson D, et al
    Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
    PLoS One. 2017;12:e0185877.
    PubMed     Text format     Abstract available


  327. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    PubMed     Text format     Abstract available


  328. CLARK A, Black R, Tate J, Roose A, et al
    Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
    PLoS One. 2017;12:e0183392.
    PubMed     Text format     Abstract available


  329. TI J, Li Z, Li X, Lu Y, et al
    Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
    PLoS One. 2017;12:e0181177.
    PubMed     Text format     Abstract available


  330. C GUARDO A, Gomez CE, Diaz-Brito V, Pich J, et al
    Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2017;12:e0186602.
    PubMed     Text format     Abstract available


  331. KAZADI EK, Tshilenge GM, Mbao V, Njoumemi Z, et al
    Determinants of dog owner-charged rabies vaccination in Kinshasa, Democratic Republic of Congo.
    PLoS One. 2017;12:e0186677.
    PubMed     Text format     Abstract available


  332. MONAMELE GC, Vernet MA, Njankouo MR, Victoir K, et al
    Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2017;12:e0184411.
    PubMed     Text format     Abstract available


  333. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    PubMed     Text format     Abstract available


  334. ROSE J, Homa L, Meropol SB, Debanne SM, et al
    Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    PLoS One. 2017;12:e0187446.
    PubMed     Text format     Abstract available


  335. GRANDAHL M, Larsson M, Dalianis T, Stenhammar C, et al
    Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.
    PLoS One. 2017;12:e0187193.
    PubMed     Text format     Abstract available


  336. DIALLO AO, Soeters HM, Yameogo I, Sawadogo G, et al
    Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    PLoS One. 2017;12:e0187466.
    PubMed     Text format     Abstract available


  337. ABIR T, Ogbo FA, Stevens GJ, Page AN, et al
    The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
    PLoS One. 2017;12:e0187090.
    PubMed     Text format     Abstract available


  338. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    PubMed     Text format     Abstract available


  339. CAFIERO-FONSECA ET, Stawasz A, Johnson ST, Sato R, et al
    The full benefits of adult pneumococcal vaccination: A systematic review.
    PLoS One. 2017;12:e0186903.
    PubMed     Text format     Abstract available


  340. CIONCADA R, Maddaluno M, Vo HTM, Woodruff M, et al
    Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    PLoS One. 2017;12:e0185843.
    PubMed     Text format     Abstract available


  341. FURUKAWA K, Tanemura M, Miyoshi E, Eguchi H, et al
    A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes.
    PLoS One. 2017;12:e0184901.
    PubMed     Text format     Abstract available


  342. SASTRY M, Zhang B, Chen M, Joyce MG, et al
    Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
    PLoS One. 2017;12:e0186854.
    PubMed     Text format     Abstract available


  343. LI H, Nykoluk M, Li L, Liu LR, et al
    Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0186079.
    PubMed     Text format     Abstract available


  344. FABIANI M, Ferrante G, Minardi V, Giambi C, et al
    Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015).
    PLoS One. 2017;12:e0178122.
    PubMed     Text format     Abstract available


  345. SORIA I, Quattrocchi V, Langellotti C, Gammella M, et al
    Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.
    PLoS One. 2017;12:e0185184.
    PubMed     Text format     Abstract available


  346. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Text format     Abstract available


  347. SAMIAK L, Emeto TI
    Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2017;12:e0187796.
    PubMed     Text format     Abstract available


  348. ALVAREZ-ZUZEK LG, La Rocca CE, Iglesias JR, Braunstein LA, et al
    Epidemic spreading in multiplex networks influenced by opinion exchanges on vaccination.
    PLoS One. 2017;12:e0186492.
    PubMed     Text format     Abstract available


  349. OKU A, Oyo-Ita A, Glenton C, Fretheim A, et al
    Perceptions and experiences of childhood vaccination communication strategies among caregivers and health workers in Nigeria: A qualitative study.
    PLoS One. 2017;12:e0186733.
    PubMed     Text format     Abstract available


  350. JAMAL SB, Hassan SS, Tiwari S, Viana MV, et al
    An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriae.
    PLoS One. 2017;12:e0186401.
    PubMed     Text format     Abstract available


  351. DECAMP AC, Rolland M, Edlefsen PT, Sanders-Buell E, et al
    Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
    PLoS One. 2017;12:e0185959.
    PubMed     Text format     Abstract available


  352. BUCHAN SA, Chung H, Campitelli MA, Crowcroft NS, et al
    Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.
    PLoS One. 2017;12:e0187834.
    PubMed     Text format     Abstract available


  353. HARALAMBIEVA IH, Gibson MJ, Kennedy RB, Ovsyannikova IG, et al
    Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
    PLoS One. 2017;12:e0188149.
    PubMed     Text format     Abstract available


  354. DE BRUYN J, Thomson PC, Bagnol B, Maulaga W, et al
    The chicken or the egg? Exploring bi-directional associations between Newcastle disease vaccination and village chicken flock size in rural Tanzania.
    PLoS One. 2017;12:e0188230.
    PubMed     Text format     Abstract available


  355. SOBHKHEZ M, Krasnov A, Chang CJ, Robertsen B, et al
    Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus.
    PLoS One. 2017;12:e0188456.
    PubMed     Text format     Abstract available


  356. SENAPATI R, Nayak B, Kar SK, Dwibedi B, et al
    HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    PLoS One. 2017;12:e0187844.
    PubMed     Text format     Abstract available


  357. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Text format     Abstract available


  358. RALEIGH MD, Peterson SJ, Laudenbach M, Baruffaldi F, et al
    Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
    PLoS One. 2017;12:e0184876.
    PubMed     Text format     Abstract available


  359. BOMMANA S, Walker E, Desclozeaux M, Timms P, et al
    Humoral immune response against two surface antigens of Chlamydia pecorum in vaccinated and naturally infected sheep.
    PLoS One. 2017;12:e0188370.
    PubMed     Text format     Abstract available


  360. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2017;12:e0184540.
    PubMed     Text format     Abstract available


  361. KUZNIK A, Iliyasu G, Lamorde M, Mahmud M, et al
    Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    PLoS One. 2017;12:e0188595.
    PubMed     Text format     Abstract available



  362. Correction: Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    PLoS One. 2017;12:e0189039.
    PubMed     Text format     Abstract available


  363. PRAPHASIRI P, Ditsungnoen D, Sirilak S, Rattanayot J, et al
    Predictors of seasonal influenza vaccination among older adults in Thailand.
    PLoS One. 2017;12:e0188422.
    PubMed     Text format     Abstract available


  364. CAYATTE C, Snell Bennett A, Rajani GM, Hostetler L, et al
    Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
    PLoS One. 2017;12:e0188708.
    PubMed     Text format     Abstract available


  365. CHAISRI U, Tungtrongchitr A, Indrawattana N, Meechan P, et al
    Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.
    PLoS One. 2017;12:e0188627.
    PubMed     Text format     Abstract available


  366. XING J, Singh S, Zhao Y, Duan Y, et al
    Increasing vaccine production using pulsed ultrasound waves.
    PLoS One. 2017;12:e0187048.
    PubMed     Text format     Abstract available


  367. MEUNIER M, Guyard-Nicodeme M, Vigouroux E, Poezevara T, et al
    Promising new vaccine candidates against Campylobacter in broilers.
    PLoS One. 2017;12:e0188472.
    PubMed     Text format     Abstract available


  368. MURRAY J, Todd KV, Bakre A, Orr-Burks N, et al
    A universal mammalian vaccine cell line substrate.
    PLoS One. 2017;12:e0188333.
    PubMed     Text format     Abstract available


  369. BRUXELLE JF, Mizrahi A, Hoys S, Collignon A, et al
    Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    PLoS One. 2017;12:e0187212.
    PubMed     Text format     Abstract available


  370. JEE PF, Tiong V, Shu MH, Khoo JJ, et al
    Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    PLoS One. 2017;12:e0187718.
    PubMed     Text format     Abstract available


  371. LIM J, Kim K, Choi S, Park SM, et al
    The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    PLoS One. 2017;12:e0189210.
    PubMed     Text format     Abstract available


  372. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2017;12:e0188807.
    PubMed     Text format     Abstract available


  373. KIM YG, Baltabekova AZ, Zhiyenbay EE, Aksambayeva AS, et al
    Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector.
    PLoS One. 2017;12:e0189308.
    PubMed     Text format     Abstract available


  374. RAJARAM S, Wiecek W, Lawson R, Blak BT, et al
    Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    PLoS One. 2017;12:e0186739.
    PubMed     Text format     Abstract available


  375. ARCURI M, Di Benedetto R, Cunningham AF, Saul A, et al
    The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
    PLoS One. 2017;12:e0189100.
    PubMed     Text format     Abstract available


  376. MWILA-KAZIMBAYA K, Garcia MP, Bosomprah S, Laban NM, et al
    Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia.
    PLoS One. 2017;12:e0189351.
    PubMed     Text format     Abstract available


  377. PLACE DE, Williamson DR, Yuzefpolskiy Y, Katkere B, et al
    Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.
    PLoS One. 2017;12:e0190384.
    PubMed     Text format     Abstract available


  378. MCMORROW ML, Emukule GO, Obor D, Nyawanda B, et al
    Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants?
    PLoS One. 2017;12:e0189623.
    PubMed     Text format     Abstract available


  379. MWAPE I, Bosomprah S, Mwaba J, Mwila-Kazimbaya K, et al
    Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
    PLoS One. 2017;12:e0187761.
    PubMed     Text format     Abstract available


  380. ZORENC Z, Veberic R, Slatnar A, Koron D, et al
    A wild 'albino' bilberry (Vaccinium myrtillus L.) from Slovenia shows three bottlenecks in the anthocyanin pathway and significant differences in the expression of several regulatory genes compared to the common blue berry type.
    PLoS One. 2017;12:e0190246.
    PubMed     Text format     Abstract available


  381. KODAY MT, Leonard JA, Munson P, Forero A, et al
    Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
    PLoS One. 2017;12:e0189780.
    PubMed     Text format     Abstract available


  382. TARTOF S, Cohn A, Tarbangdo F, Djingarey MH, et al
    Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt.
    PLoS One. 2017;12:e0190188.
    PubMed     Text format     Abstract available


  383. SUNTRONWONG N, Klinfueng S, Vichiwattana P, Korkong S, et al
    Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    PLoS One. 2017;12:e0189511.
    PubMed     Text format     Abstract available


  384. IKEGAMI T, Balogh A, Nishiyama S, Lokugamage N, et al
    Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.
    PLoS One. 2017;12:e0189250.
    PubMed     Text format     Abstract available


  385. BENNETT A, Nagelkerke N, Heinsbroek E, Premkumar PS, et al
    Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres.
    PLoS One. 2017;12:e0190256.
    PubMed     Text format     Abstract available


  386. PECENKA C, Munthali S, Chunga P, Levin A, et al
    Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.
    PLoS One. 2017;12:e0190006.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: